| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 746 | 2016 |
| Tuberculosis: advances and challenges in development of new diagnostics and biomarkers G Walzl, R McNerney, N du Plessis, M Bates, TD McHugh, NN Chegou, ... The Lancet Infectious Diseases 18 (7), e199-e210, 2018 | 311 | 2018 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 256 | 2018 |
| Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report N Chegou, G Black, M Kidd, P van Helden, G Walzl BMC pulmonary medicine 9 (1), 21, 2009 | 216 | 2009 |
| Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis NN Chegou, J Heyckendorf, G Walzl, C Lange, M Ruhwald European Respiratory Journal 43 (5), 1472-1486, 2014 | 197 | 2014 |
| High level of discordant IGRA results in HIV-infected adults and children AM Mandalakas, AC Hesseling, NN Chegou, HL Kirchner, X Zhu, ... The International Journal of Tuberculosis and Lung Disease 12 (4), 417-423, 2008 | 188 | 2008 |
| Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome R Tadokera, G Meintjes, KH Skolimowska, KA Wilkinson, K Matthews, ... European Respiratory Journal 37 (5), 1248-1259, 2011 | 180 | 2011 |
| Host blood RNA signatures predict the outcome of tuberculosis treatment EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ... Tuberculosis 107, 48-58, 2017 | 167 | 2017 |
| Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and … NN Chegou, JS Sutherland, S Malherbe, AC Crampin, PLAM Corstjens, ... Thorax 71 (9), 785-794, 2016 | 167 | 2016 |
| Highly discordant T cell responses in individuals with recent exposure to household tuberculosis AC Hesseling, AM Mandalakas, HL Kirchner, NN Chegou, BJ Marais, ... Thorax 64 (10), 840, 2009 | 115 | 2009 |
| RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ... Scientific reports 10 (1), 8629, 2020 | 104 | 2020 |
| Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response R Jacobs, S Malherbe, AG Loxton, K Stanley, G Van Der Spuy, G Walzl, ... Oncotarget 7 (36), 57581, 2016 | 100 | 2016 |
| Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting NN Chegou, GF Black, AG Loxton, K Stanley, PN Essone, MR Klein, ... BMC infectious diseases 12, 1-14, 2012 | 99 | 2012 |
| Tuberculosis assays: past, present and future NN Chegou, KGP Hoek, M Kriel, RM Warren, TC Victor, G Walzl Expert Review of Anti-infective Therapy 9 (4), 457-469, 2011 | 98 | 2011 |
| Evaluation of adapted whole-blood interferon-γ release assays for the diagnosis of pleural tuberculosis NN Chegou, G Walzl, CT Bolliger, AH Diacon, MM van den Heuvel Respiration 76 (2), 131-138, 2008 | 91 | 2008 |
| Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting NN Chegou, AK Detjen, L Thiart, E Walters, AM Mandalakas, ... PloS one 8 (5), e64226, 2013 | 87 | 2013 |
| Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses OR Ayepola, NN Chegou, NL Brooks, OO Oguntibeju BMC Complementary and Alternative Medicine 13, 1-9, 2013 | 84 | 2013 |
| Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment R Jacobs, E Tshehla, S Malherbe, M Kriel, AG Loxton, K Stanley, ... Cytokine 81, 50-56, 2016 | 75 | 2016 |
| Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area NN Chegou, PN Essone, AG Loxton, K Stanley, GF Black, ... PloS one 7 (6), e38501, 2012 | 74 | 2012 |
| Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis JF Djoba Siawaya, NN Chegou, MM Heuvel, AH Diacon, N Beyers, ... Cytokine 47 (2), 132-136, 2009 | 74 | 2009 |
